Post-transition: Pharmacovigilance requirements for UK authorised products - Thursday 22 October 2020
Posted by:
Kiernan Trevett, Emily Cannell and Anne Ambrose, Posted on:
-
Categories:
Compliance matters, Events and symposia, Good pharmacovigilance practice, Wider MHRA
Post-transition: Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020. This webinar was part of a series of EU Exit and post-transition guidance webinars.
